# Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

> **NCT04069299** · — · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Neuroendocrine Carcinoma

## Interventions

- **DRUG:** 68Ga-DOTATATE
- **DIAGNOSTIC_TEST:** Positron Emission Tomography (PET) Scan

## Key facts

- **NCT ID:** NCT04069299
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-25
- **Primary completion:** 2025-06-02
- **Final completion:** 2025-06-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04069299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04069299, "Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04069299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*